314 related articles for article (PubMed ID: 28817827)
1. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Szurian K; Kashofer K; Liegl-Atzwanger B
Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
[TBL] [Abstract][Full Text] [Related]
2. What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution's Experience.
Kulaç İ; Bulutay P; Meriçöz ÇA
Turk Patoloji Derg; 2021; 37(3):226-232. PubMed ID: 34514574
[TBL] [Abstract][Full Text] [Related]
3. [Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors].
Bertram S; Schildhaus HU
Pathologe; 2020 Nov; 41(6):589-605. PubMed ID: 32965532
[TBL] [Abstract][Full Text] [Related]
4. [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].
Schmitz K; Schildhaus HU
Pathologe; 2015 Mar; 36(2):126-36. PubMed ID: 25822596
[TBL] [Abstract][Full Text] [Related]
5. Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing.
Lam SW; Cleton-Jansen AM; Cleven AHG; Ruano D; van Wezel T; Szuhai K; Bovée JVMG
J Mol Diagn; 2018 Sep; 20(5):653-663. PubMed ID: 30139549
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
7. [Molecular biology for sarcoma: useful or necessary?].
Neuville A; Coindre JM; Chibon F
Ann Pathol; 2015 Jan; 35(1):107-13. PubMed ID: 25533919
[TBL] [Abstract][Full Text] [Related]
8. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
9. Sarcoma molecular testing: diagnosis and prognosis.
Lazar AJ; Trent JC; Lev D
Curr Oncol Rep; 2007 Jul; 9(4):309-15. PubMed ID: 17588356
[TBL] [Abstract][Full Text] [Related]
10. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
Marino-Enriquez A
Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
[TBL] [Abstract][Full Text] [Related]
11. Targeted RNA sequencing: A routine ancillary technique in the diagnosis of bone and soft tissue neoplasms.
Dickson BC; Swanson D
Genes Chromosomes Cancer; 2019 Feb; 58(2):75-87. PubMed ID: 30350361
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
13. Contemporary Sarcoma Diagnosis, Genetics, and Genomics.
Schaefer IM; Cote GM; Hornick JL
J Clin Oncol; 2018 Jan; 36(2):101-110. PubMed ID: 29220288
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors.
Chebib I; Taylor MS; Nardi V; Rivera MN; Lennerz JK; Cote GM; Choy E; Lozano Calderón SA; Raskin KA; Schwab JH; Mullen JT; Chen YE; Hung YP; Nielsen GP; Deshpande V
Am J Surg Pathol; 2021 Aug; 45(8):1127-1137. PubMed ID: 34115673
[TBL] [Abstract][Full Text] [Related]
15. [The pathologic diagnosis of bone and soft tissue tumors: update].
Nojima T
Rinsho Byori; 2014 Jun; 62(6):578-85. PubMed ID: 25151777
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
Gusho CA; Weiss MC; Lee L; Gitelis S; Blank AT; Wang D; Batus M
Acta Oncol; 2022 Jan; 61(1):38-44. PubMed ID: 34686105
[No Abstract] [Full Text] [Related]
17. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
[TBL] [Abstract][Full Text] [Related]
18. [The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas].
Niu XH; Xu HR
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2399-2404. PubMed ID: 36000368
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
Mariño-Enríquez A; Bovée JV
Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
[TBL] [Abstract][Full Text] [Related]
20. Primary paediatric epidural sarcomas: molecular exploration of three cases.
Low SYY; Kuick CH; Seow WY; Bte Syed Sulaiman N; Chen H; Lian DWQ; Chang KTE; Tan EEK; Soh SY; Tan GIL; Ng LP; Seow WT; Low DCY
BMC Cancer; 2019 Feb; 19(1):182. PubMed ID: 30819134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
